Tomas Koltai (Former Medical Director, Hospital del Centro Gallego de Buenos Aires, Argentina): pH Deregulation as the Eleventh Hallmark of Cancer
Tomas Koltai (Former Medical Director, Hospital del Centro Gallego de Buenos Aires, Argentina)
, Larry Fliegel (Professor, Associate Chair, Department of Biochemistry, Faculty of Medicine, University of Alberta, Canada)
, Stephan J. Reshkin (Associate Professor, Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, Italy)
, Baltazar, Fatima (Associate Professor, Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal)
, Rosa Angela Cardone (Associate Professor, Department of Biosciences, Biotechnologies, and Biopharmaceutics, University of Bari, Italy)
, Alfarouk, Khalid Omer, PhD (Assistant Professor, Alfarouk Biomedical Research LLC, Temple Terrace, FL, USA; Hala Alfarouk Cancer Center, Khartoum, Sudan)
, Afonso, Julieta (Post-doctoral researcher, Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Portugal)
pH Deregulation as the Eleventh Hallmark of Cancer
Buch
Lieferzeit beträgt mind. 4 Wochen
(soweit verfügbar beim Lieferanten)
(soweit verfügbar beim Lieferanten)
EUR 178,86*
Verlängerter Rückgabezeitraum bis 31. Januar 2024
Alle zur Rückgabe berechtigten Produkte, die zwischen dem 1. bis 31. Dezember 2023 gekauft wurden, können bis zum 31. Januar 2024 zurückgegeben werden.
- Elsevier Science Publishing Co Inc, 06/2023
- Einband: Kartoniert / Broschiert
- Sprache: Englisch
- ISBN-13: 9780443154614
- Bestellnummer: 11546575
- Umfang: 190 Seiten
- Gewicht: 538 g
- Maße: 276 x 212 mm
- Stärke: 13 mm
- Erscheinungstermin: 30.6.2023
Achtung: Artikel ist nicht in deutscher Sprache!
Klappentext
pH Deregulation as the Eleventh Hallmark of Cancer presents key concepts about pH deregulation in a concise and straight-forward manner. The book discusses topics such as pH regulation and metabolism, sodium hydrogen exchanger, monocarboxylate transporter, V-ATPase proton pump, carbonic anhydrases, and voltage gated sodium channels. In addition, it covers clinical and therapeutic implications and future perspectives. This is a valuable resource for researchers, oncologists, students and members of the biomedical and medical fields who want to learn more about the role of pH deregulation in cancer treatment.pH deregulation can improve the outcome of classical treatments without adding toxicity to them, and the book shows that treating the pH peculiarities of cancer is simple and can be performed with existing drugs. Based on the classification of tumor malignancy in ten hallmarks, the authors put pH deregulation at the spotlight and separated from metabolic reprogramming due to its impact on all other hallmarks, proposing it as an additional characteristic to evaluate and fight cancer.